Non small cell lung cancer medical therapy stage II

Non Small Cell Lung Cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Non Small Cell Lung Cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-Ray
CT Scan
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Management Approach Stage I Stage II Stage III Stage IV Metastatic Cancer
Medical Therapy Chemotherapy Radiation Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Non small cell lung cancer medical therapy stage II On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Non small cell lung cancer medical therapy stage II All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Non small cell lung cancer medical therapy stage II
CDC on Non small cell lung cancer medical therapy stage II
Non small cell lung cancer medical therapy stage II in the news
Blogs on Non small cell lung cancer medical therapy stage II
Directions to Hospitals Treating Non small cell carcinoma of the lung
Risk calculators and risk factors for Non small cell lung cancer medical therapy stage II

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alonso Alvarado, M.D. [2]